ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,599.00
15.50 (0.98%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  15.50 0.98% 1,599.00 1,599.50 1,600.50 1,600.00 1,575.00 1,579.50 5,149,016 16:35:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.37 65.87B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,583.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £65.87 billion. Gsk has a price to earnings ratio (PE ratio) of 13.37.

Gsk Share Discussion Threads

Showing 10976 to 10996 of 33100 messages
Chat Pages: Latest  448  447  446  445  444  443  442  441  440  439  438  437  Older
DateSubjectAuthorDiscuss
12/7/2015
21:55
Scottishfield,

Thanks for your contribution! I sometimes forget what I was about to say!!!

jadeticl3
11/7/2015
12:51
Companies should only pay a dividend if they have not got a better use for the money. The new budget rules on dividend taxes will align the UK with the US. There companies tend to pay dividends sparingly because of double taxation. It is a major reason why buy backs are used more often in the US than the UK.
greenpastures2
09/7/2015
16:14
Earnings yield is more important than distribution yield in any case.
hpcg
08/7/2015
17:00
I think its a good thing sometimes. Aviva used to have a high yield and everytime the results came around the focus was solely on the dividend - this lead to a lot of speculation and column inches and I think it took the focus off the results. They cut it to a more sustainable level and the share price has performed strongly.

I'm not saying that it would be the same with GSK, but if its becomes close to unsustainable cut it.

dr biotech
08/7/2015
16:54
Appreciate that perspective and many are in a similar position,
GSK will want to buy out the remaining Novartis OTC stake imv
and that will require a big investment.

I can see the longer term potential here, not currently holding.

essentialinvestor
08/7/2015
16:26
I'd certainly view it as negative if they "rebase", a sleazy euphemism for cut, because I only invest in shares for income. In line with my strat, I wouldn't sell unless such a cut drops the yield to the FTSE but I certainly would not be pleased about it because it would hit my income.

Cuts are the risk I take for investing in shares for income but I see nothing positive about them at all. I don't believe in trading lower divis for growth for two reasons. First, I don't care about share prices and second even if I did, I have no faith that cutting the divi would produce a measurable trade off in share price growth.

The difference between GSK and those others you mention is that I don't think that TSCO etc made a similar commitment to a certain divi figure for a three year period as GSK has done. So I'd guess it is much more likely than not that GSK will stick to their plan. In any event there's little point in speculating about it for me, because it doesn't influence my reasons for holding or selling the share.

anhar
08/7/2015
12:57
Rebasing of the dividend in 2016 IMV, as per TSCO, CNA, SBRY... it's a long list.

Just to add I would not view it as a negative development if in the context of an
enhanced growth orientated strategy, this is speculation on my part.

essentialinvestor
08/7/2015
12:07
I've got no interest in brokers' views. No divis are guaranteed but I'm inclined to believe the GSK 80p three year commitment plus the 20p special for the first year. That makes a yield of about 5.9% at 1,347p even without the special, which is a big premium over the FTSE.

Whatever happens though I'll stick to my income strat and hold GSK until its yield falls to the FTSE or forever, whichever comes first. Even my own beliefs about the GSK commitment are irrelevant to the strat.

anhar
08/7/2015
10:21
The Liberum take on GSK is interesting.

The central theme is that the status quo cannot be maintained, the dividend
commitment over 3 years may lack credibility given the number of times GSK
has not delivered on targets.

They appear to see a dividend cut as part of a new strategic plan giving GSK more
flexibility to acquire, for example, the remainder of Novartis's stake in
the OTC business and further invest in their franchises to drive growth.

essentialinvestor
08/7/2015
08:01
Let's face it, the European experiment has failed - political, economic and social
tradermichael
06/7/2015
06:47
I think you are wrong Monty. If Greece leaves the Euro the Germans and, to a lesser extent, the French will pay for the exit. The Euro requires a quasi national constitution in order to work not the petty national squabbling that is the current make up of the EU. The ECB has to take control, not the politicians. That means printing money and handing that money to the Greeks, Irish, Portugese, Spanish and Italians. In other words regional development in an international situation.
darias
06/7/2015
06:09
The non tax payer Greeks are in for a shock. How stupid are they.
montyhedge
05/7/2015
20:48
Seems Greeks are going to get away with it.
racg
05/7/2015
20:25
What price tomorrow?
tompion
03/7/2015
21:34
Huge multi year support in this area.



free stock charts from uk.advfn.com

tim 3
03/7/2015
21:24
Agreed. Give us the methadone breezers, Witty!
racg
03/7/2015
20:54
Essential, GSK should supply PI shareholders with their products for free, especially those tablets which treat nervous disorders as the problem has probably been caused by the company!
jadeticl3
02/7/2015
16:22
There is great long term(3-5 years) value here imv, very tradable in the
meantime.

Would not like to count how many of their products I use,
at least two, including one off label - for which I needed to sign
a multi page disclaimer )

essentialinvestor
02/7/2015
16:18
Sitting on a few
badtime
02/7/2015
15:41
added a few
phillis
01/7/2015
11:28
Sold a few but keep the majority.
essentialinvestor
Chat Pages: Latest  448  447  446  445  444  443  442  441  440  439  438  437  Older

Your Recent History

Delayed Upgrade Clock